VANCOUVER, BC – Genome BC is pleased to announce the new “Applied Genomics Innovation Program” (AGIP). The AGIP is a $40M program with an initial investment of up to $20M from Genome BC. It is designed to support applied genome sciences-derived innovations for specifically targeted sectors of BC's economy. The AGIP is focused on achieving practical applications within three to five years and is expected to support both small and large scale research projects.

Genome sciences hold great potential to address many of the critical challenges facing British Columbians today, from the health of our environment to the health of our citizens to the health of our economy.

Genome BC is therefore focused on the application of genomic sciences for the future of British Columbia. For example, capabilities created by the six successful health projects funded in 2004/05 (with approved budgets of $44.1 million) under the Applied Genomics and Proteomics Research in Human Health Competition are already contributing to the development of new approaches to solving a variety of human health problems.

Over the next year, Genome BC will introduce other new “Applied Genomics” initiatives of strategic importance to the Province to expand our existing capabilities in translating discovery science to everyday life.
 
About Genome British Columbia:
Genome BC is a catalyst for the life sciences sector as it invests in, and manages, large-scale genomics and proteomics research projects and technology platforms.  Research is focused on areas of strategic importance including BC's key economic sectors such as health, agriculture, forestry, fisheries, mining, bio-energy and the environment.  With 32 projects and technology platforms in its portfolio, Genome BC's approved research program is over $300 million. Working collaboratively with all levels of government, universities and industry, both nationally and internationally, Genome BC has positioned itself as a leader for a vibrant, genomics-driven life sciences cluster with far reaching social and economic benefits for the Province and Canada.

For further information please contact:
Julia White
Communications Officer
Genome British Columbia
T: 604 637 4378